AMERICAN INTERNATIONAL GROUP, INC. - AIMMUNE THERAPEUTICS INC ownership

AIMMUNE THERAPEUTICS INC's ticker is AIMT and the CUSIP is 00900T107. A total of 1 filers reported holding AIMMUNE THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
AMERICAN INTERNATIONAL GROUP, INC. ownership history of AIMMUNE THERAPEUTICS INC
ValueSharesWeighting
Q3 2020$958,000
+101.7%
27,804
-2.2%
0.01%
+150.0%
Q2 2020$475,000
+23.7%
28,437
+6.7%
0.00%0.0%
Q1 2020$384,000
-59.3%
26,641
-5.5%
0.00%
-50.0%
Q4 2019$943,000
+60.6%
28,179
+0.4%
0.00%
+100.0%
Q3 2019$587,000
-0.2%
28,055
-0.7%
0.00%0.0%
Q2 2019$588,000
-5.8%
28,249
+1.2%
0.00%0.0%
Q1 2019$624,000
-9.4%
27,915
-3.1%
0.00%
-33.3%
Q4 2018$689,000
-12.1%
28,820
+0.3%
0.00%0.0%
Q3 2018$784,000
+3.3%
28,728
+1.8%
0.00%0.0%
Q2 2018$759,000
+5.0%
28,211
+24.1%
0.00%0.0%
Q1 2018$723,000
-19.3%
22,726
-4.1%
0.00%0.0%
Q4 2017$896,000
+53.2%
23,704
+0.5%
0.00%
+50.0%
Q3 2017$585,000
+30.3%
23,591
+8.1%
0.00%0.0%
Q2 2017$449,000
+27.6%
21,827
+34.9%
0.00%
+100.0%
Q1 2017$352,000
+13.9%
16,184
+7.1%
0.00%0.0%
Q4 2016$309,000
-99.9%
15,114
-0.3%
0.00%0.0%
Q3 2016$227,310,000
+38.8%
15,154
+0.2%
0.00%0.0%
Q2 2016$163,717,000
+88.2%
15,131
+135.7%
0.00%
Q1 2016$87,000,0006,4200.00%
Other shareholders
AIMMUNE THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Foresite Capital Management II, LLC 3,100,146$117,248,00040.96%
TLP GROUP LLC 1,050,000$39,711,00027.53%
Aisling Capital LLC 2,240,000$84,717,00016.74%
Foresite Capital Management III, LLC 764,824$28,926,0008.12%
AlpInvest Partners B.V. 51,498$1,948,0006.95%
Vivo Capital, LLC 643,626$24,342,0005.21%
GREAT POINT PARTNERS LLC 573,550$21,692,0003.70%
Eventide Asset Management 1,226,000$46,367,0002.42%
Palo Alto Investors LP 1,146,419$43,358,0001.87%
HAMILTON LANE ADVISORS LLC 78,846$2,982,0001.54%
View complete list of AIMMUNE THERAPEUTICS INC shareholders